21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
#13202Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent
#13203Combinations comprising epothilones and pharmaceutical uses thereof
#13204Method of activation of oxazaphosphorines
#13205COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#13206Statins for the Treatment of Viral Influenza Infections
#13207Antibiotic combinations for providing total solution to the treatment of infections
#13208MEANS AND METHODS FOR MODULATING STEM CELL MOBILIZATION
#13209Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
#13210Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take
#13211Eyelid Preparation and Method of Use
#13212DANDRUFF TREATMENT COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS INCLUDING BOTANIC SEED OILS
#13213Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders
#13214Composition comprising and extracts for the treatment and prevention of inflammatory diseases
#13215Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof
#13216Skin Protectant Spray Compositions
#13217Salivary substitute
#13218METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#13219COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A GLUCOCORTICOSTEROID FOR TREATMENT OF ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE OR ALLERGIC RHINITIS
#13220COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#13221COMBINATION ANTITUMOR THERAPIES
#13222COMPOSITION FOR ORAL USE BASED ON S-ADENOSYLMETHIONINE AND A PROCESS FOR THEIR PREPARATION
#13223Water-insoluble, iron-containing mixed metal, granular material
#13224USE OF ONCOLYTIC VIRUSES AND ANTIANGIOGENIC AGENTS IN THE TREATMENT OF CANCER
#13225REVERSE TARGETING LIPID VESICLE
#13226Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#13227Whole blood-derived coagulum device for treating bone defects
#13228Methods for processing substrates having an antimicrobial coating
#13229Tl1a in treatment of disease
#13230TREATMENT OF METASTATIC BREAST CANCER
#13231Methods using immunomodulatory compounds for modulating level of CD59
#13232Methods of using death receptor ligands and cd20 antibodies
#13233CANCER TREATMENT METHOD
#13234Antimicrobial composition and uses thereof
#13235Therapy procedure for drug delivery for trigeminal pain
#13236Compositions And Methods For Lipo Modeling
#13237SMALL MOLECULES FOR THE REDUCTION OF HIGH BLOOD GLUCOSE LEVEL
#13238Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases
#13239NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS
#13240ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION
#13241Deodorant agent
#13242Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
#13243TREATMENT OF VR1-ANTAGONIST-INDUCED INCREASE IN BODY TEMPERATURE WITH AN ANTIPYRETIC AGENT
#13244Methods for eradicating lice and fleas from a host
#13245Medicament for Use in Connection With Cartilage Impairment
#13246Cleavable carnitine compound
#13247Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
#13248METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS
#13249Substituted arylpyrazoles
#13250COMBINATION OF MODAFINIL AND AN ANTAGONIST OR INVERSE AGONIST OF THE H3 RECEPTOR
#13251NOVEL PHARMACEUTICAL COMPOSITIONS FOR TREATING ACQUIRED CHRONIC PAIN AND ASSOCIATED DYSPHORIA
#13252Antineoplastic Combinations Containing HKI-272 and Vinorelbine
#13253METHOD FOR MANAGEMENT OF DIARRHEA
#13254Compositions comprising balaglitazone and further antidiabetic compounds
#13255Compositions containing alpha-2-adrenergic agonist components
#13256Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders
#13257ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES
#13258Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
#13259Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia
#13260Multi-carotenoids compositions and methods
#13261HISTONE DEACETYLASE INHIBITORS WITH COMBINED ACTIVITY ON CLASS-I AND CLASS-IIB HISTONE DEACETYLASES IN COMBINATION WITH PROTEASOME INHIBITORS
#13262COMBINATION THERAPY OF (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PYRAZOL-4-YL)-1-OXO-2,6-DIHYDRO-1H-[1,2]DIAZEPINO[4,5,6-CD]INDOL-8-YL)ACETAMIDE
#13263Antimicrobial compositions
#13264Compositions comprising dimethyl sulfoxide (DMSO)
#13265Transglutaminase inhibitors and methods of use thereof
#13266LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS
#13267Methods of effecting Wnt signaling through Dkk structural analysis
#13268Antimicrobial Activity in Variants of Lacritin
#13269COMPOSITION CONTAINING A CEREAL MILLING PRODUCT
#13270Compositions for alleviating inflammation and oxidative stress in a mammal
#13271Combination therapy for bipolar disorder
#13272METHOD FOR TREATING ACNE
#13273Thiazole compounds, and compositions and methods using same
#13274Method for activating and stabilizing dissolved hydrogen in water
#13275USE OF XENON AS NEUROPROTECTANT IN A NEONATAL SUBJECT
#13276COMBINATION OF A TRIPTAN AND AN NSAID
#13277MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT
#13278Transdermal hormone delivery system: compositions and methods
#13279NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#13280Nucleic acid compositions for stimulating immune responses
#13281Nucleic acid encoding 238P1B2 useful in detecting cancer
#13282Gene constructs coding for CD40-binding activating antibodies
#13283CD40 ANTIBODY FORMULATION AND METHODS
#13284Capecitabine Combination Therapy
#13285VEGF165 Delivered by Fibrin Sealant to Reduce Tissue Necrosis
#13286TOPICAL COMPOSITION AND TREATMENT METHOD FOR CARTILAGE DAMAGE
#13287Combination therapy using a soluble hyaluronidase and a bisphosphonate
#13288Therapeutic Peptide Compositions And Methods Of Making And Using Same
#13289Agent for use in the case of fructose intolerance
#13290PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
#13291Composition
#13292Method for treating cervical cancer
#13293Lipoxin analogs and methods for the treatment of periodontal disease
#13294Methods for treating thyroid cancer
#13295Method and apparatus for determining acetabular component positioning
#13296Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association
#13297Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#13298METHODS FOR IMPROVING DRUG DISPOSITION
#13299TREATMENT FOR DEPRESSIVE DISORDERS
#13300Non-Codeine Opioid Analgesic Process And Formulations
#13301Use of Lck inhibitors for treatment of immunologic diseases
#13302COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
#13303COMBINATION OF ROSCOVITINE AND A HDCA INHIBITOR TO TREAT PROLIFERATIVE DISEASES
#13304ANTIMALARIAL THERAPY USING A COMBINATION OF SYNTHETIC ARTEMISININ DERIVATIVE AND BISQUINOLINE DERIVATIVE
#13305Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds
#13306Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
#13307Mono and Combination Therapy of M1/M4 Agonist (Sabcomeline) for Treatment of Negative Symptoms of Schizophrenia
#13308Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity
#13309Use of picoplatin to treat colorectal cancer
#13310COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS
#13311GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISM
#13312Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
#13313Method and composition for skin inflammation and discoloration
#13314Combination preparations of o-acetylsalicylic acid salts
#13315STABLE ORGANIC PEROXIDE COMPOSITIONS
#13316Antimicrobial therapy for bacterial infections
#13317THERAPEUTIC PROTOCOLS
#13318USE OF NON-DIGESTABLE SACHARIDES FOR GIVING AN INFANT THE BEST START AFTER BIRTH
#13319METHODS AND COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
#13320USE OF AN INTERLEUKIN 1 RECEPTOR ANTAGONIST AND/OR PYRROLIDINEDITHIOCARBAMATE FOR THE TREATMENT OR PROPHYLAXIS OF TYPE 2 DIABETES
#13321Immunomodulatory Agents For Treatment of Inflammatory Diseases
#13322Methods and Compositions Related to TR4
#13323PHARMACEUTICAL PREPARATIONS OF A GLP-1 MOLECULE AND AN ANTI-EMETIC DRUG
#13324Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis
#13325Treatment of Ras-expressing tumors
#13326DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS
#13327Recombinant double stranded RNA nucleocapsid and use of the same
#13328Peptides Having an Ace Inhibiting Effect
#13329Laxative Composition and Method
#13330Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects
#13331Method and composition for dermatoses
#13332ESTROGENIC EXTRACTS FOR USE IN TREATING VAGINAL AND VULVAR ATROPHY
#13333Pharmaceutical Combination
#13334SOLUBILIZED BENZOYL PEROXIDE TOPICAL DRUG FORMULATION FOR THE TREATMENT OF ACNE
#13335Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
#13336METHOD AND COMPOSITION FOR TREATING AND DIAGNOSING RESTLESS LEGS SYNDROME
#13337Method of treatment for muscular dystrophy
#13338VIRUCIDAL COMPOSITIONS AND USES
#13339Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide
#13340Combinations and modes of administration of therapeutic agents and combination therapy
#13341CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#13342NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS
#13343Escalating dosing regimen for effecting weight loss and treating obesity
#13344COMPOSITIONS AND METHODS FOR TREATING BACTERIA
#13345MASTER GENE OF ARTERIOGENESIS
#13346TRANSMUCOSAL DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
#13347Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
#13348PHARMACEUTICAL FORMULATION OF LOSARTAN
#13349USE OF DMSO AND BOTULINUM TOXIN THERAPY FOR URINARY INCONTINENCE AND RELATED DISORDERS
#13350Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies
#13351Monoclonal antibodies to basic fibroblast growth factor
#13352Identification and use of prognostic and predictive markers in cancer treatment
#13353Ang2 and Vegf Inhibitor Combinations
#13354Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators
#13355METHODS OF USING CD40 BINDING AGENTS
#13356METHODS AND COMPOSITIONS FOR NEEDLELESS DELIVERY OF ANTIBODIES
#13357METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#13358Super fast-acting insulin compositions
#13359USE OF GSK-3 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
#13360Infant formula with probiotics
#13361Repair of the Bone Marrow Vasculature
#13362HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR
#13363Treating severe and acute viral infections
#13364Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions
#13365Hepatitis C virus inhibitors
#13366Once A Day Formulation for Phosphate Binders
#13367TRICYCLIC COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF
#13368Aqueous Hydrogen Peroxide Solution for Use as a Disinfectant or Anti-Microbial Personal Care Product
#13369TOPICAL STEROID SPRAY WITH BOTANIC SEED OILS
#13370Nutritional supplement
#13371COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION
#13372Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
#13373Anti-adipocyte fatty acid-binding protein (AP2), anti-flap and anti-CySLT1 receptor herbal compositions
#13374NOVEL NATURAL CYCLODEXTRIN COMPLEXES
#13375Method for the preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-y-oxo-n-β-diphenylbenzenebutanamide and products therefrom
#13376A Combination of Compounds, Which Can be Used in the Treatment of Respiratory Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
#13377Methods of screening for compounds that reduce microbial resistance to fluoroquinolones
#13378QUINOLINE COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF
#13379Pellet-form slow-release preparation for vertigo
#13380Materials and Methods Relating to the Induction of Apoptosis in Target Cells
#13381Pharmaceutical compounds
#13382ANTI-AMNESIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
#13383Pharmaceutical Compositions
#13384Combinations of adapalene and benzoyl peroxide for treating acne lesions
#13385COMBINATION THERAPY FOR THE TREATMENT OF INFLUENZA
#13386Acylgycerophospholipids for treating symptoms concomitant with cancer
#13387COMBINATIONS COMPRISING EPOTHILONES AND ANTIMETABOLITES
#13388Therapeutic use for treating of leukemia
#13389Organ arrest, protection and preservation
#13390APLIDINE TREATMENT OF CANCERS
#13391Dalbavancin compositions for treatment of bacterial infections
#13392METHODS OF ADMINISTERING DALBAVANCIN FOR TREATMENT OF BACTERIAL INFECTIONS
#13393Trophic factor combinations for nervous system treatment
#13394Functional Food Having Positive Effects in the Prevention of Cardiovascular Diseases
#13395BOTANICAL COMPOSITION AND ITS USES
#13396Herbal compositions for the treatment of mucosal lesions
#13397Nutritional composition for increasing creatine uptake in skeletal muscle
#13398Cosmetic treatement method for fighting against skin ageing effects
#13399Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
#13400AGENT FOR TREATING EYE DISEASES
#13401Formulations, devices and methods for treating and preventing mucositis
#13402COMPOSITION BENEFICIAL FOR VISUOGNOSIS PERSISTENCE AND USE THEREOF
#13403Wound Care Composition
#13404COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A TYROSINE KINASE INHIBITOR, DELTA OPIOID RECEPTOR ANTAGONIST, NEUROKININ RECEPTOR ANTAGONIST, OR VCAM INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#13405Composition and system to promote wound healing
#13406Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
#13407THERAPEUTIC COMBINATION
#13408Local Delivery of PAR-1 Antagonists to Treat Vascular Complications
#13409Identifying and modulating molecular pathways that mediate nervous system plasticity
#13410Methods for identifying a GLP-1 secretagogue
#13411ANTI-FLT3 ANTIBODIES
#13412ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272
#13413METHODS FOR TREATING IL-18 MEDIATED DISORDERS
#13414PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#13415INHIBITION OF CALPAIN REDUCES ALLERGIC INFLAMMATION
#13416USE OF CHARCOAL FOR TREATING INFLAMMATORY CONDITIONS
#13417Methods and compositions for treating nephrogenic diabetes and insipidus
#13418Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
#13419Compositions containing non-polar compounds
#13420Human T-cell population
#13421Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
#13422CYSTEINE DIOXYGENASE POLYMORPHISMS
#13423Hepatitis C virus inhibitors
#13424Methods For Autologous Stem Cell Transplantation
#13425Remedies for ischemia
#13426Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead
#13427ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS
#134283′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#13429Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
#13430DUAL OPIOID PAIN THERAPY
#13431Potentiators of Antibacterial Activity
#13432COMBINATION OF AN MEK INHIBITOR AND THE SRC KINASE INHIBITOR AZD0530 FOR USE IN THE TREATMENT OF CANCER
#13433Modulators of pharmacokinetic properties of therapeutics
#13434BICYCLIC HETEROARYL INHIBITORS OF PDE4
#13435Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking
#13436Compositions with enhanced elasticizing activity
#13437Extended cycle multiphasic oral contraceptive kit
#13438AGENT AND FOOD FOR PREVENTING/IMPROVING FUNCTIONAL DIGESTIVE DISORDER
#13439AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE
#13440Use of thiophoshonoformic acid and nrtis to treat viral infections
#13441Methods for treatment of headaches by administration of oxytocin
#13442METHODS FOR TREATING PROGRESSIVE COGNITIVE DISORDERS RELATED TO NEUROFIBRILLARY TANGLES
#13443Proteins for use in diagnosing and treating infection and disease
#13444COMBINATION OF AN IMMUNOSUPPRESSIVE AGENT AND NONSTEROIDAL ANTI -INFLAMMATORY DRUGS TO TREAT DISEASE
#13445TREATMENTS USING CITRULLINE
#13446Herbal extract pharmaceutical composition and method for treating and/or preventing of hyperlipidemia and processes for producing the same
#13447Reduced weight decontamination formulation utilizing a solid peracid compound for neutralization of chemical and biological warfare agents
#13448Combination of azelastine and mometasone for nasal administration
#13449Transdermal delivery of cannabidiol
#13450Opioid Combination Wafer
#13451Wound Care Treatment Product
#13452OSTEOGENIC COMPOSITION COMPRISING A GROWTH FACTOR/AMPHIPHILIC POLYMER COMPLEX, A SOLUBLE CATION SALT AND AN ORGANIC SUPPORT
#13453Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#13454USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES
#13455Antibodies against ErbB3 and uses thereof
#13456Anti-IL-6 antibodies, compositions, methods and uses
#13457BINDING AGENTS AND THEIR USE IN TARGETING TUMOR CELLS
#13458Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
#13459STEM CELL THERAPY FOR BLOOD VESSEL DEGENERATION
#13460Treatment of HIV
#13461Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
#13462Formula and method for treating water in fish tanks
#13463Isoindole-imide compounds, compositions, and uses thereof
#13464Hops Beta-Acid Anti-Diabetic Composition
#13465SELECTED BETAINES AND THEIR USES
#13466Preventive or Therapeutic Drug for Alzheimer-Type Dementia
#13467Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties
#13468Use of a plant oil product as an agent for increasing the synthesis of skin lipids
#13469Cancer treatment using FTS and 2-deoxyglucose
#13470Inhibition of EMT induction in tumor cells by anti-cancer agents
#13471VR1 Receptor Ligands and u-Opioid Receptor Ligands for the Treatment of Pain
#13472Treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells
#13473USE OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITORS FOR THE TREATMENT OF CANCER
#13474Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
#13475Pharmaceutical Formulations Comprising Azelastine and a Corticosteroid for the Treatment of Inflammatory or Allergic Conditions
#13476Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
#13477Compositions and methods for treating hyperproliferative diseases
#13478Methods and Compositions for Treating Conditions of the Eye
#13479METHODS AND COMPOSITIONS FOR THE TREATMENT OF XEROSTOMIA
#13480OSCILLATOR CIRCUIT, TRANSCEIVER, AND METHOD FOR GENERATING OSCILLATORY SIGNAL
#13481COMPOSITION COMPRISING COMPLEX CRUDE DRUG EXTRACTS SHOWING ANTI-ALLERGIC RHINITIS, ANTI-ATOPIC DERMATITIS AND ANTI-ASTHMA ACTIVITY
#13482Synergistic pharmaceutical composition, method of making same and use of same
#13483Composition comprising thunb. extract, blume extract, or herbal mixture extract thereof
#13484Food Supplement and Method for Enhancing Athletic Performance
#13485Cynara scolymus extracts, the use thereof and formulations containing them
#13486COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A BETA-AGONIST BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#13487COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A METHYLXANTHINE DERIVATIVE FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#13488COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTICHOLINERGIC BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#13489Antimicrobial peroxidase compositions
#13490Thiosemicarbazones as anti-virals and immunopotentiators
#13491Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
#13492NOVEL MEMORY CTL INDUCTION POTENTIATOR
#13493IL-8 as a biomarker for sunitinib resistance
#13494COMBINATION DRUGS COMPRISING VEGF INHIBITOR AND SERINE PROTEASES/THROMBOLYTIC COMPOUNDS FOR TREATING NEOVASCULAR DISORDERS
#13495Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
#13496CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
#13497Highly concentrated stabilized IgM solution
#13498Fermented cereal product obtained by fermentation of rye bran with a Lactobacillus curvatus strain
#13499Compositions and methods for treatment of neovascular diseases
#13500Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders